Skip to main content
OpenTrials

Clinical trial condition

Immune Checkpoint Inhibitors (ICIs)

Explore clinical trials studying Immune Checkpoint Inhibitors (ICIs). Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies

Immune Checkpoint Inhibitors (ICIs) trial results

Conditions
Arterial Thromboembolism, Cardiovascular Diseases, Embolism and Thrombosis, +12 more
Locations
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The Fourth Hospital of Inner Mongolia Autonomous Region Hohhot, Inner Mongolia, China
  • Beijing Chaoyang Hospital, Capital Medical University Beijing, China
  • Beijing Luhe Hospital, Capital Medical University Beijing, China
Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Hunan Cancer Hospital Changsha, China
  • The Second Xiangya Hospital of Central South University Changsha, China
  • The Third Hospital of Changsha Changsha, China
  • Xiangya Hospital of Central South University Changsha, China
View all 20 locations
Conditions
Adenocarcinoma, Cancer, Treatment-Related, Carcinoma, +14 more
Locations
  • The Second Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
  • The Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • Shaoyang Central Hospital Shaoyang, Hunan, China